Kazia Therapeutics (KZIA) Return on Assets Growth (5y) (2014 - 2025)

Kazia Therapeutics (KZIA) Return on Assets Growth (5y) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn -
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn
7 Belite Bio 63.44 Bn 63.44 Bn -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn
10 Kazia Therapeutics 19.25 Bn 19.25 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Jun 30, 2025 0.00
Dec 31, 2024 0.00
Jun 30, 2024 0.00
Dec 31, 2023 0.00
Jun 30, 2023 1.00
Dec 31, 2022 1.00
Jun 30, 2022 1.00
Dec 31, 2021 1.00
Jun 30, 2021 1.00
Dec 31, 2020 0.00
Jun 30, 2020 0.00
Dec 31, 2019 4.00
Jun 30, 2019 0.00
Dec 31, 2018 0.00
Jun 30, 2018 0.00
Dec 31, 2017 -1.00
Dec 31, 2016 -2.00
Jun 30, 2016 0.00
Dec 31, 2014 -4.00